← Back to Search

Alternate Day Intermittent Energy Restriction for Obesity (AltER2022 Trial)

N/A
Waitlist Available
Led By Martin Binks, Ph.D.
Research Sponsored by Texas Tech University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 week
Awards & highlights
No Placebo-Only Group

Summary

This trialwill compare a new intermittent diet to a standard one to see if it helps reduce weight and body fat in college students with obesity.

Eligible Conditions
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Body Weight
Fat Mass
Resting Metabolic Rate

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Alternate Day Intermittent Energy RestrictionExperimental Treatment1 Intervention
Participants assigned to this diet will be asked to alternate between full calorie (no restriction) eating days with eating 40% of their daily caloric requirement on the other day. For example, if their requirement is 2000 calories they would eat 800 calories one day and as much as you want on the other day and repeat every two days. There will be occasional exceptions allowed with maximum of two 40% days in a row (followed by two full days) based on personal schedule with prior approval. They will follow this for 4 weeks.
Group II: Reduced Calorie DietActive Control1 Intervention
Participants assigned to this diet will be asked to restrict calorie intake by 500-1000 calories below their daily energy requirement every day. They will follow this for 4 weeks.

Find a Location

Who is running the clinical trial?

Texas Tech UniversityLead Sponsor
82 Previous Clinical Trials
9,262 Total Patients Enrolled
10 Trials studying Obesity
509 Patients Enrolled for Obesity
Martin Binks, Ph.D.Principal InvestigatorTexas Tech University- Department of Nutritional Sciences
1 Previous Clinical Trials
58 Total Patients Enrolled
~4 spots leftby Dec 2025